Epigenome Technologies provides quantitative chromatin profiling products and services for research teams investigating gene regulation. Its portfolio combines validated assays, sequencing-compatible kits, and expert scientific support to help researchers examine epigenetic signals and gene expression at single-cell and population levels.

Products include Paired-Tag kits, which profile chromatin and RNA together, and single-cell CUT&Tag kits compatible with 10x Chromium, Illumina PIPseq, and BD Rhapsody systems. The company’s services cover single-cell Paired-Tag, CUT&Tag, CUT&Tag plus RNA, and ATAC-seq, as well as bulk CUT&Tag, CUT&RUN, ChIP-seq, ATAC-seq, RNA-seq, and DNA methylation. These workflows can assess histone modifications, transcription factors, chromatin accessibility, and transcriptomes across supported sample types.

Epigenome Technologies emphasizes transparent quality control, comprehensive reporting, and consultation with PhD scientists who help design experiments, troubleshoot antibodies, and interpret findings. Customers can choose full-service projects from sample processing through analysis or select individual workflow components. The company reports a standard turnaround of two to four weeks and provides publication-ready data, quality metrics, and scientific insights to support discovery and validation.